Corium Initiates Phase 1 Clinical Trial of Corplex^TM Donepezil Transdermal System for the Treatment of Alzheimer’s Disease
MENLO PARK, Calif. , Aug. 25, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the commencement of dosing in a Phase 1…